Quick Answer
MYRIAD GENETICS INC reported Net Income Loss of -$365.90 million for the year ending 2025.
- MYRIAD GENETICS INC showed a decrease of -187.4% in Net Income Loss from 2024 to 2025.
- This data is from MYRIAD GENETICS INC's annual report (Form 10-K), filed with the SEC on February 24, 2026.
- XBRL data for this metric is available from 2009 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 18 years of available data (2009 to 2025), MYRIAD GENETICS INC's Net Income Loss has declined by 532.4%.
- Historical annual values: Fiscal year 2025: -$365.90 million | Fiscal year 2024: -$127.30 million | Fiscal year 2023: -$263.30 million | Fiscal year 2022: -$112.00 million | Fiscal year 2021: -$27.20 million | Fiscal year 2020: -$223.60 million | Fiscal year 2020: -$199.50 million | Fiscal year 2019: $4.60 million | Fiscal year 2018: $133.30 million | Fiscal year 2017: $17.40 million | Fiscal year 2016: $117.20 million | Fiscal year 2015: $79.80 million | Fiscal year 2014: $176.20 million | Fiscal year 2013: $147.20 million | Fiscal year 2012: $112.15 million | Fiscal year 2011: $100.71 million | Fiscal year 2010: $152.30 million | Fiscal year 2009: $84.62 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: